Trade Daré Bioscience, Inc. - DARE CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0864 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 2.9018 |
Open | 2.8818 |
1-Year Change | 500.25% |
Day's Range | 2.8718 - 2.8918 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 2, 2025 | 2.9018 | 0.0300 | 1.04% | 2.8718 | 2.9618 | 2.8718 |
Apr 1, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.9118 | 2.8718 |
Mar 31, 2025 | 2.8818 | 0.0100 | 0.35% | 2.8718 | 2.8918 | 2.8718 |
Mar 28, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8818 | 2.8718 |
Mar 27, 2025 | 2.8818 | 0.0100 | 0.35% | 2.8718 | 2.8818 | 2.8718 |
Mar 26, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8818 | 2.8718 |
Mar 25, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8818 | 2.8718 |
Mar 24, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8818 | 2.8718 |
Mar 21, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8918 | 2.8418 |
Mar 20, 2025 | 2.8718 | -0.0400 | -1.37% | 2.9118 | 2.9418 | 2.8718 |
Mar 19, 2025 | 2.9118 | 0.0400 | 1.39% | 2.8718 | 2.9118 | 2.8718 |
Mar 18, 2025 | 2.8718 | -0.0200 | -0.69% | 2.8918 | 2.8918 | 2.8718 |
Mar 17, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.9018 | 2.8418 |
Mar 14, 2025 | 2.8718 | -0.0400 | -1.37% | 2.9118 | 2.9618 | 2.8718 |
Mar 13, 2025 | 2.9118 | -0.0800 | -2.67% | 2.9918 | 2.9918 | 2.9018 |
Mar 12, 2025 | 2.9918 | 0.0600 | 2.05% | 2.9318 | 3.0118 | 2.9318 |
Mar 11, 2025 | 2.9418 | 0.0000 | 0.00% | 2.9418 | 2.9418 | 2.8118 |
Mar 10, 2025 | 2.9418 | 0.0000 | 0.00% | 2.9418 | 2.9418 | 2.8918 |
Mar 7, 2025 | 2.9418 | -0.0800 | -2.65% | 3.0218 | 3.0218 | 2.8818 |
Mar 6, 2025 | 3.0218 | 0.0000 | 0.00% | 3.0218 | 3.0418 | 2.9918 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Daré Bioscience, Inc. Company profile
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women''s health in the United States. The company develops therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel formulated with clindamycin phosphate 2% to treat bacterial vaginosis in a single administration that has completed Phase 3 clinical trials; Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company''s Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ORB-204 and ORB-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company is headquartered in San Diego, California.Industry: | Biotechnology & Medical Research (NEC) |
3655 Nobel Dr Ste 260
SAN DIEGO
CALIFORNIA 92122-1050
US
News

Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com